Home - Products - Cell Cycle/DNA Damage - GPR - Ogremorphin

Ogremorphin

CAS No. 352563-21-4

Ogremorphin( —— )

Catalog No. M37230 CAS No. 352563-21-4

Ogremorphin (GPR68-IN-1) is a potent inhibitor of GPR68 with an EC50 of 170 nM, used in the study of autoimmune chronic inflammatory diseases .

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	606	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Ogremorphin
Note

Research use only, not for human use.
Brief Description

Ogremorphin (GPR68-IN-1) is a potent inhibitor of GPR68 with an EC50 of 170 nM, used in the study of autoimmune chronic inflammatory diseases .
Description

Ogremorphin (GPR68-IN-1) is a potent GPR68 inhibitor with an EC50of 170 nM. Ogremorphin is extracted from patent WO2020214896 (OGM1), and can be used for autoimmune chronic inflammatory diseases research.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Cell Cycle/DNA Damage
Target

GPR
Recptor

GPR
Research Area

——
Indication

——

Chemical Information

CAS Number

352563-21-4
Formula Weight

359.44
Molecular Formula

C21H17N3OS
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 50 mg/mL (139.11 mM; Ultrasonic )
SMILES

O=C1NC2=CC=C(C=C2C31SC(=NN3)C=4C=CC=C5C=CC=CC54)CC
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Charles C. Hong, et al. Small molecule inhibitors of gpcr gpr68 and related receptors. Patent WO2020214896.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

AMG-009

AMG-009 is a selective and potent dual antagonist of CRTH2 and DP, with an IC50 value of 3 nM for CRTH2 and 12 nM for DP receptors.
GLPG1205

GLPG1205 is a potent, orally active GPR84 (G protein-coupled receptor) antagonist with anti-inflammatory activity. GLPG1205 shows good PK/PD characteristics and can be used to study pulmonary fibrosis.
TAK-875 hemihydrate

Fasiglifam (TAK-875) is a selective GPR40 agonist with EC50 of 14 nM in human GPR40 expressing CHO cell line.

Sign In Join Free